SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-035956
Filing Date
2017-07-07
Accepted
2017-07-06 18:32:08
Documents
3
Period of Report
2017-06-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v470439_8k.htm 8-K 18142
2 EXHIBIT 99.1 v470439_ex99-1.htm EX-99.1 10600
3 GRAPHIC image_001.jpg GRAPHIC 3976
  Complete submission text file 0001144204-17-035956.txt   35743
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 17953521
SIC: 2834 Pharmaceutical Preparations